Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.30 |
| ▸ | PDE1A | P54750 | 1/20 | 0.30 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333096 | 0.79 | PDE1A (0.32) | MAP3K12PDE1APDE1BPDE1C | |
| SCHEMBL17025860 | 0.75 | HDAC6 (0.40) | MAP3K12PDE1APDE1BPDE1C | |
| SCHEMBL332904 | 0.74 | MAP3K12 (0.36) | MAP3K12PDE1APDE1BPDE1C | |
| SCHEMBL28689628 | 0.73 | CNR1 (0.39) | MAP3K12PDE1APDE1BPDE1C | |
| SCHEMBL5647105 | 0.73 | HDAC6 (0.37) | MAP3K12PDE1APDE1BPDE1C | |
| SCHEMBL31582660 | 0.71 | HCRTR2 (0.35) | MAP3K12 | |
| SCHEMBL333238 | 0.71 | OPRL1 (0.36) | — | |
| SCHEMBL333924 | 0.70 | MAP3K12 (0.32) | MAP3K12 | |
| SCHEMBL333414 | 0.70 | OPRM1 (0.35) | MAP3K12 | |
| SCHEMBL17027153 | 0.70 | MAP3K12 (0.44) | MAP3K12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097733-B2 | Pyrazole derivatives as 5-LO-inhibitors | PFIZER INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-20090227634-A1 | Pyrazole Derivatives as 5-LO-Inhibitors | PFIZER INC. | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227634-A1 | Pyrazole Derivatives as 5-LO-Inhibitors | ALOX5, ALOX15, CYP3A5 | MAP3K12 2120/4885PDE1A 2090/4885PDE1B 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.